Skip to content
Investors Dashboard
Contact
TwitterFacebookInstagramLinkedinYouTube
  • English
TwitterFacebookInstagramLinkedinYouTube
  • English
Pharmamar S.A
Pharmamar S.A.
Pharmamar S.APharmamar S.A
  • About PharmaMar
    • Senior Management
    • Management Team PharmaMar
    • Board of directors
    • Other Business
    • PharmaMar in the World
    • Corporate Responsibility
    • Our History
  • Patients
    • Therapeutic Indications
    • Collaboration with Patient Associations
    • Clinical trial
  • Products
    • YONDELIS®
    • Lurbinectedin
  • Science & Innovation
    • R&D and Innovation
    • Virology Unit
      • Our Vision
      • Molecular Pharmacodynamics
      • COVID-19, Clinical Development
      • COVID-19, Translational Strategy
    • Oncology Pipeline
    • Cofinanced Projects
    • Collaboration with Scientific Associations
    • Publications
    • Mechanisms of Action
    • Medical meeting presentations
  • Shareholders and Investors
    • Financial Information
      • Annual Reports
      • Interim financial information
      • Financial Statements (Zeltia)
      • Average Period of Payment to Suppliers
    • Notifications sent to CNMV
    • Share Information
      • Share Performance
      • Shares Outstanding
      • Dividends
      • Significant Shareholding & Company Owned-Stock
      • Analysts
    • Debt Obligations
    • Presentations
    • General Shareholders Meetings
    • Corporate Governance
      • Corporate Bylaws
      • General Shareholders’ Meeting Regulations
      • Shareholder Agreements
      • Board of Directors
      • Board of Directors Regulation
      • Annual Report on Corporate Governance
      • Annual Director Remuneration Report
      • Board Committees
      • Internal Regulation Governing Conduct
      • Director Selection Policy
    • Contact
    • Merger PharmaMar-Zeltia
    • General Policy of Communication
    • Sustainability Policy
    • Director’s Compensation Policy
  • Newsroom
    • Press Releases
    • Events calendar
    • Multimedia
      • Videos
      • Infographics
    • Medical meeting presentations
  • Careers
    • Benefits
    • Send us your CV
    • About PharmaMar
      • Senior Management
      • Management Team PharmaMar
      • Board of directors
      • Other Business
      • PharmaMar in the World
      • Corporate Responsibility
      • Our History
    • Patients
      • Therapeutic Indications
      • Collaboration with Patient Associations
      • Clinical trial
    • Products
      • YONDELIS®
      • Lurbinectedin
    • Science & Innovation
      • R&D and Innovation
      • Virology Unit
        • Our Vision
        • Molecular Pharmacodynamics
        • COVID-19, Clinical Development
        • COVID-19, Translational Strategy
      • Oncology Pipeline
      • Cofinanced Projects
      • Collaboration with Scientific Associations
      • Publications
      • Mechanisms of Action
      • Medical meeting presentations
    • Shareholders and Investors
      • Financial Information
        • Annual Reports
        • Interim financial information
        • Financial Statements (Zeltia)
        • Average Period of Payment to Suppliers
      • Notifications sent to CNMV
      • Share Information
        • Share Performance
        • Shares Outstanding
        • Dividends
        • Significant Shareholding & Company Owned-Stock
        • Analysts
      • Debt Obligations
      • Presentations
      • General Shareholders Meetings
      • Corporate Governance
        • Corporate Bylaws
        • General Shareholders’ Meeting Regulations
        • Shareholder Agreements
        • Board of Directors
        • Board of Directors Regulation
        • Annual Report on Corporate Governance
        • Annual Director Remuneration Report
        • Board Committees
        • Internal Regulation Governing Conduct
        • Director Selection Policy
      • Contact
      • Merger PharmaMar-Zeltia
      • General Policy of Communication
      • Sustainability Policy
      • Director’s Compensation Policy
    • Newsroom
      • Press Releases
      • Events calendar
      • Multimedia
        • Videos
        • Infographics
      • Medical meeting presentations
    • Careers
      • Benefits
      • Send us your CV

    en User Dashboard

    You are here:
    1. Home
    2. en User Dashboard
    Calendario de Eventos
    « March 2021 » loading...
    M T W T F S S
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    1
    2
    3
    4
    Wed 10

    II Curso ONCOFIR

    March 10
    Fri 12

    Approccio diagnostico terapeutico al trattamento dei STM: l’importanza del un team multidisciplinare in un centro di riferimento

    March 12
    Wed 24

    ELCC (Lung)

    March 24

    PHARMA MAR, S.A.
    VAT: ESA-78267176

    Avda. De los Reyes, 1
    Pol. Ind. La Mina
    28770 - Colmenar Viejo
    Madrid, Spain
    How to get here

    34 91 846 6000
    34 91 846 6001
    pharmamar@pharmamar.com
    If you wish to inform of an adverse event, please click here

    Legal Notice
    Privacy Policy
    Cookies Policy

    Copyright © 2021 PharmaMar - All Rights Reserved
     Dream-Theme — truly premium WordPress themes
    Sobre PharmaMar
    Go to Top
    We use our own and third-party cookies in order to collect statistical information and to ensure the best experience on our site. If you want to accept them, click I agree.I agreeI do not acceptPrivacy policy
    You can revoke your consent any time using the Revoke consent button.Revoke consent